Get the Stockscreener App
0.0479
16.86%
-0.0177
Acutus Medical Inc stock is traded at $0.0479, with a volume of 19,726.
It is down -16.86% in the last 24 hours and down -71.77% over the past month.
See More
Previous Close:
$0.0656
Open:
$0.042
24h Volume:
19,726
Relative Volume:
66.00
Market Cap:
$N/A
Revenue:
$19.66M
Net Income/Loss:
$-32.79M
P/E Ratio:
-0.0386
EPS:
-1.24
Net Cash Flow:
$-60.99M
1W Performance:
-16.86%
1M Performance:
-71.77%
6M Performance:
-76.88%
1Y Performance:
-93.82%
1-Day Range:
$0.042
$0.0489
1-Week Range:
$0.042
$0.0489
52-Week Range:
$0.042
$0.0489
Acutus Medical Inc Stock (AFIB) Company Profile
Compare AFIB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AFIB
Acutus Medical Inc
|
0.0479 | 0 | 19.66M | -32.79M | -60.99M | -1.24 |
|
ABT
Abbott Laboratories
|
131.93 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Acutus Medical Inc Stock (AFIB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-22-21 | Initiated | Goldman | Neutral |
| Jul-15-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-19-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-19-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-14-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-31-20 | Initiated | BTIG Research | Buy |
| Aug-31-20 | Initiated | BofA Securities | Buy |
| Aug-31-20 | Initiated | Canaccord Genuity | Hold |
| Aug-31-20 | Initiated | JP Morgan | Overweight |
| Aug-31-20 | Initiated | William Blair | Outperform |
View All
Acutus Medical Inc Stock (AFIB) Latest News
Acutus Medical Reports Strong Revenue Growth in 2024 - TipRanks
Acutus Medical earnings beat by $0.36, revenue fell short of estimates - Investing.com Canada
Acutus Medical reports operating loss of USD 0.1 million in FY 24 - Medical Buyer
Acutus Medical Reports Full Year 2024 Financial Results -March 24, 2025 at 04:02 pm EDT - Marketscreener.com
Acutus Medical Reports Full Year 2024 Financial Results - TradingView
Acutus Medical (NASDAQ:AFIB) and InfuSystem (NYSE:INFU) Head to Head Comparison - Defense World
AFIB LAWSUIT ALERT: Levi & Korsinsky Notifies Acutus Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Marketscreener.com
Electrophysiology Market Trends & Growth | Industry Size, Share - openPR
Acutus Medical Inc to Host Earnings Call - ACCESS Newswire
Contrasting Acutus Medical (NASDAQ:AFIB) and Stevanato Group (NYSE:STVN) - Defense World
Acutus Medical strikes deal with Deerfield Funds, amends credit - Investing.com India
Electrophysiology Market: Opportunities, Challenges, - openPR
Reviewing Minerva Surgical (NASDAQ:UTRS) and Acutus Medical (NASDAQ:AFIB) - Defense World
Acutus Medical (NASDAQ:AFIB) & NEXGEL (NASDAQ:NXGL) Financial Review - Defense World
Layoffs in medtech: These companies recently reduced their workforce - Mass Device
Acutus Medical to cut 70% of staff, focus on Medtronic deal - Modern Healthcare
Acutus will cut 70% of employees to meet Medtronic obligations - MedTech Dive
Acutus Medical Restructures Workforce Amid Strategic Shift - TipRanks
Acutus Medical Announces Operational Downsizing - The Manila Times
Acutus Medical Slashes 70% of Workforce in Major Restructuring, Pivots to Medtronic-Only Operations - StockTitan
Acutus Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Acutus Medical Reports Q3 2024 Financial Results - TipRanks
Acutus Medical revenue jumps 156% to 5.3M in Q3 2024 - Medical Buyer
Acutus Medical revises credit agreement terms - Investing.com
Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results - The Manila Times
Acutus Medical earnings beat by $0.38, revenue fell short of estimates - Investing.com UK
Acutus Medical Revenue Surges 156% in Q3, Achieves Positive Operating Income | AFIB Stock News - StockTitan
Medtronic Receives FDA Approval of Mapping and Ablation System and Catheter - Diagnostic and Interventional Cardiology
Electrophysiology Market is expected to generate a revenue of USD 13.29 Billion by 2031, Globally, at 11.47% CAGR: Verified Market Research® - GlobeNewswire Inc.
Acutus Medical finalizes settlement with Biotronik, ends agreements By Investing.com - Investing.com Canada
Acutus Medical finalizes settlement with Biotronik, ends agreements - Investing.com
Acutus Medical Resolves Arbitration with Biotronik and VascoMed - TipRanks
Atrial Flutter Market to Rise, 2032 | Acutus Medical, ARCA - openPR
Heart Hospital of New Mexico at Lovelace Medical Center and GE HealthCare Collaborate to Install the First Allia IGS Pulse Electrophysiology Lab in the United States for Minimally Invasive Cardiovascular Procedures - Diagnostic and Interventional Cardiology
Acutus Medical delisted from Nasdaq market due to non-compliance - MassDevice
Why Is Acutus Medical (AFIB) Stock Down 41% Today? - InvestorPlace
Acutus Medical Full Year 2023 Earnings: US$0.41 loss per share (vs US$1.40 loss in FY 2022) - Simply Wall St
Acutus Medical Faces Biotronik Contract Termination Dispute - TipRanks
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Benzinga
Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Acutus laying off 65% of employees to focus solely on Medtronic heart device deal - MedTech Dive
Acutus torches ablation business to focus on manufacturing - BioWorld MedTech
Acutus Medical is laying off more than half of its workers - MassDevice
Electrophysiology Catheters Market size to grow by USD 2.24 billion from 2022-2027| Abbott Laboratories, Acutus Medical Inc., and Johnson and Johnson are some of the major companies in the marketTechnavio - PR Newswire
Transcript : Acutus Medical, Inc., Q1 2023 Earnings Call, May 11, 2023 - Marketscreener.com
Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation at the 2023 AF Symposium - Diagnostic and Interventional Cardiology
Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic - Diagnostic and Interventional Cardiology
Corewell Health Grows Robotic Program to Treat Heart Rhythm Disorders with Adoption of Stereotaxis’ Genesis System - Diagnostic and Interventional Cardiology
Acutus Medical Third Quarter 2022 Earnings: EPS Beats Expectations - Yahoo Finance
Acutus Medical, Inc. (AFIB) Reports Q3 Loss, Tops Revenue Estimates - Yahoo News UK
With stock in yearlong freefall, Acutus Medical hit with threat of Nasdaq delisting - Fierce Biotech
Acutus Medical Inc Stock (AFIB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.55%
Cap:
|
Volume (24h):